ORIGINAL RESEARCH
Published on 12 Dec 2024
Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity
doi 10.3389/fphar.2024.1397995
- Frontiers in Pharmacology
- Inflammation Pharmacology
- Research Topics
- Rheumatoid Arthritis: Discovery of Potential Therapeutic Targets
Rheumatoid Arthritis: Discovery of Potential Therapeutic Targets
4,249
Total Downloads
15k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 24 Apr 2024
Comparative efficacy of five approved Janus kinase inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis: a systematic review and network meta-analysis of randomized controlled trials
doi 10.3389/fphar.2024.1387585
- 3,255 views
ORIGINAL RESEARCH
Published on 21 Mar 2024
Novel mechanistic study of HDAC6 regulation of rheumatoid arthritis via CMA: exploring potential therapeutic targets
doi 10.3389/fphar.2024.1383663
- 826 views
ORIGINAL RESEARCH
Published on 04 Jan 2024
Exploratory analysis on the relationship between dietary live microbe intake and arthritis: a national population based cross-sectional study
doi 10.3389/fnut.2023.1328238
- 1,806 views
- 1 citation
REVIEW
Published on 15 Nov 2023
Immunomodulatory roles of metalloproteinases in rheumatoid arthritis
doi 10.3389/fphar.2023.1285455
- 3,956 views
- 9 citations
MINI REVIEW
Published on 06 Nov 2023
Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application
doi 10.3389/fphar.2023.1306584
- 1,758 views
- 3 citations
Published in
Frontiers in Pharmacology
- Inflammation Pharmacology
Participating Journals
Frontiers in Immunology
Inflammation PharmacologyOffline
- 5.7 impact factor
- 9.8 citescore
Impact
- 15kTopic views
- 9,234Article views
- 4,249Article downloads